Girish Shroff
Interventional Cardiology · Jacksonville, FLNPI 1336105519
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,731 of the $5,065 with a category attached, or 73.7%. 34 manufacturers reported payments, led by GE HealthCare at 28.2% of the total. Reporting peaked in 2019 at $2,108 and has fallen 93.6% since, to $135 in 2023. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.
Across 182 payments — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$1K
- Abbott$653
- Amgen$369
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$345
- Johnson & Johnson$314
- Merck$302
- plus $2K from 28 others
Across 31 payments — averaging $2598.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$81K
What the payments were for
- Travel & lodging$1,19224%
- Food & beverage$3,73174%
- Education$1423%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 4 | $1,427 |
| Abbott | 6 | $653 |
| Amgen | 24 | $369 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $345 |
| Johnson & Johnson | 20 | $314 |
| Merck | 17 | $302 |
| Pfizer | 15 | $231 |
| Shockwave Medical, Inc | 2 | $151 |
| Novartis | 9 | $143 |
| E.r. Squibb & Sons, L.L.C. | 8 | $134 |
| AstraZeneca | 9 | $123 |
| Biotronik Inc. | 2 | $94 |
| Esperion Therapeutics, Inc. | 4 | $89 |
| Medtronic(2 entities) | 5 | $84 |
| Impulse Dynamics (USA) Inc. | 3 | $67 |
| Boehringer Ingelheim | 3 | $65 |
| Amarin Pharma, Inc. | 3 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $50 |
| Boston Scientific | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Cvrx, Inc. | 1 | $27 |
| Bayer | 1 | $25 |
| Abiomed | 2 | $24 |
| Chiesi USA, Inc. | 2 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Gilead | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,065 in reported general payments places this provider in the 35th percentile of 623 interventional cardiology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Jacksonville
- Siddharth WayangankarJacksonville$1.2M
- Dominick AngiolilloJacksonville$387K
- Ruby SatpathyJacksonville$205K
- Bharat GummadiJacksonville$153K
- Raguveer MurthyJacksonville$65K
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.